Diagnosis of endocrine disease: limitations of the IGF1 generation test in children with short stature.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  European Journal of Endocrinology

• Publication date

  2012-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1530/EJE-11-0618PMID 22048966
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Endocrine regulation of longitudinal bone growth.

  2011cited by this paper
• Off-label use of recombinant igf-I to promote growth: is it appropriate?

  2010cited by this paper
• Recombinant insulin-like growth factor (IGF)-I treatment in short children with low IGF-I levels: first-year results from a randomized clinical trial.

  2010cited by this paper
• Systematic analysis of G protein-coupled receptor gene expression in adrenocorticotropin-independent macronodular adrenocortical hyperplasia identifies novel targets for pharmacological control of adrenal Cushing's syndrome.

  2010cited by this paper
• Growth hormone and insulin-like growth factor I insensitivity of fibroblasts isolated from a patient with an I{kappa}B{alpha} mutation.

  2010cited by this paper
• Short Stature in Partially Corrected X-linked Severe Combined Immunodeficiency - Suboptimal Response to Growth Hormone

  2008cited by this paper
• European perspective on treatment approaches for growth failure.

  2008cited by this paper
• IGF-I assays: current assay methodologies and their limitations

  2007cited by this paper
• The insulin-like growth factor-I response to growth hormone is increased in prepubertal children with obesity and tall stature.

  2007cited by this paper
• Long-term treatment with recombinant insulin-like growth factor (IGF)-I in children with severe IGF-I deficiency due to growth hormone insensitivity.

  2007cited by this paper
• Exon 3‐deleted genotype of growth hormone receptor (GHRd3) positively influences IGF‐1 increase at generation test in children with idiopathic short stature

  2007cited by this paper
• IGF-I, IGFBP-3 and ALS generation test in Turner syndrome.

  2007cited by this paper
• The correlation of the IGF-I, IGFBP-3, and ALS generation test to height velocity after 6 months of recombinant growth hormone therapy in girls with Turner syndrome.

  2006cited by this paper
• The d3-growth hormone (GH) receptor polymorphism is associated with increased responsiveness to GH in Turner syndrome and short small-for-gestational-age children.

  2006cited by this paper
• Insulin-Like Growth Factor (IGF) Parameters and Tools for Efficacy: The IGF-I Generation Test in Children

  2005cited by this paper
• Severe growth hormone insensitivity resulting from total absence of signal transducer and activator of transcription 5b.

  2005cited by this paper
• IGFs and IGFBPs in GH insensitivity.

  2005cited by this paper
• Insulin-like growth factor-I response to a single bolus of growth hormone is increased in obesity.

  2005cited by this paper
• Clinical, Biochemical and Molecular Investigations of Three Taiwanese Children with Laron Syndrome

  2004cited by this paper
• Standard and low‐dose IGF‐I generation tests and spontaneous growth hormone secretion in children with idiopathic short stature

  2004cited by this paper
• A common polymorphism of the growth hormone receptor is associated with increased responsiveness to growth hormone

  2004cited by this paper
• Divergent effect of endogenous and exogenous sex steroids on the insulin-like growth factor I response to growth hormone in short normal adolescents.

  2004cited by this paper
• Primary GH insensitivity '(Laron syndrome) caused by a novel 4 kb deletion encompassing exon 5 of the GH receptor gene: effect of intermittent long-term treatment with recombinant human IGF-I.

  2004cited by this paper
• The impact of dose and route of estrogen administration on the somatotropic axis in normal women.

  2003cited by this paper
• Insulin-like growth factors and the basis of growth.

  2003cited by this paper
• Growth hormone insensitivity associated with a STAT5b mutation.

  2003cited by this paper
• Poor reproducibility of IGF-I and IGF binding protein-3 generation test in children with short stature and normal coding region of the GH receptor gene.

  2002cited by this paper
• Insulin-like growth factor binding protein-3 generation as a measure of GH sensitivity.

  2002cited by this paper
• Biochemical markers of growth hormone (GH) sensitivity in children with idiopathic short stature: individual capacity of IGF‐I generation after high‐dose GH treatment determines the growth response to GH

  2002cited by this paper
• Insulin-Like Growth Factor I (IGF-I) and IGF-Binding Protein 3 Response to Growth Hormone Is Impaired in HIV-Infected Children

  2002cited by this paper
• IGF generation in short stature.

  2002cited by this paper
• Abnormal GH receptor signaling in children with idiopathic short stature.

  2001cited by this paper
• Novel application of IGF‐I and IGFBP‐3 generation tests in the diagnosis of growth hormone axis disturbances in children with β‐thalassaemia

  2001cited by this paper
• The IGF-I generation test revisited: a marker of GH sensitivity.

  2001cited by this paper
• Body composition, fasting leptin, and sex steroid administration determine GH sensitivity in peripubertal short children.

  2001cited by this paper
• Study of growth hormone secretion and action in growth-retarded children with juvenile chronic arthritis (JCA).

  1999cited by this paper
• Short‐term increments of insulin‐like growth factor I (IGF‐I) and IGF‐binding protein‐3 predict the growth response to growth hormone (GH) therapy in GH‐sensitive children

  1999cited by this paper
• Changes in serum IGF‐I and IGFBP‐3 concen_trations during the IGF‐I generation test performed prospectively in children with short stature

  1998cited by this paper
• Pharmacological testing for the diagnosis of growth hormone deficiency.

  1998cited by this paper
• GH response to provocation and circulating IGF-I and IGF-binding protein-3 concentrations, the IGF-I generation test and clinical response to GH therapy in children with beta-thalassaemia.

  1998cited by this paper
• Pharmacological testing for thediagnosis of growth hormone deficiency

  1998cited by this paper
• Phenotype: genotype relationships in growth hormone insensitivity syndrome.

  1997cited by this paper
• Growth deficiency in polytransfused β‐thalassaemia patients is not growth hormone dependent

  1997cited by this paper
• Insulin-Like Growth Factor Binding Protein-3 Generation: An Index of Growth Hormone Insensitivity

  1996cited by this paper
• Review of Turkish patients with growth hormone insensitivity (Laron type).

  1995cited by this paper
• Improvement of diagnostic criteria in growth hormone insensitivity syndrome: solutions and pitfalls

  1994cited by this paper
• Laron syndrome: clinical features, molecular pathology and treatment.

  1994cited by this paper
• Growth hormone (GH) insensitivity due to primary GH receptor deficiency.

  1994cited by this paper
• The growth hormone and somatomedin axis in short children with osteogenesis imperfecta.

  1993cited by this paper
• Diverse growth hormone receptor gene mutations in Laron syndrome.

  1993cited by this paper
• Clinical features and endocrine status in patients with growth hormone insensitivity (Laron syndrome).

  1993cited by this paper
• Constancy of somatomedin response to growth hormone treatment of hypopituitary dwarfism, and lack of correlation with growth rate.

  1981cited by this paper
• Lack of response of nonsuppressible insulin-like activity to short term administration of human growth hormone in thalassemia major.

  1981cited by this paper

• Growth hormone treatment adjusted for growth hormone sensitivity in idiopathic short stature.

  2025cites this paper
• Laron syndrome in South Indian children – A descriptive study

  2023cites this paper
• Clinical profile of Laron dwarfism – experience from a tertiary care institute in Chennai

  2023cites this paper
• Challenges in the care of individuals with severe primary insulin-like growth factor-I deficiency (SPIGFD): an international, multi-stakeholder perspective

  2023cites this paper
• Short Stature due to Bioinactive Growth Hormone (Kowarski Syndrome).

  2023cites this paper
• Inclusion and Withdrawal Criteria for Growth Hormone (GH) Therapy in Children with Idiopathic GH Deficiency—Towards Following the Evidence but Still with Unresolved Problems

  2022cites this paper
• Evaluating the sensitivity and specificity of the UK and Dutch growth referral criteria in predicting the diagnosis of pathological short stature

  2022cites this paper
• Treatment for Infertility in Laron Syndrome: A Case Report

  2022cites this paper
• Comprehensive genetic testing approaches as the basis for personalized management of growth disturbances: current status and perspectives

  2022cites this paper
• Growth failure: ‘idiopathic’ only after a detailed diagnostic evaluation

  2021cites this paper
• Differential Diagnosis of the Short IGF-I-Deficient Child with Apparently Normal Growth Hormone Secretion

  2021cites this paper
• Genetic Characterization of Short Stature Patients With Overlapping Features of Growth Hormone Insensitivity Syndromes

  2021cites this paper
• Balanced assessment of growth disorders using clinical, endocrinological, and genetic approaches

  2021cites this paper
• Laron syndrome: An experience of treatment of two cases

  2021cites this paper
• The continuum between GH deficiency and GH insensitivity in children

  2020cites this paper
• Are the Effects of Oral and Vaginal Contraceptives on Bone Formation in Young Women Mediated via the Growth Hormone-IGF-I Axis?

  2020cites this paper
• Significance of Direct Confirmation of Growth Hormone Insensitivity for the Diagnosis of Primary IGF-I Deficiency

  2020cites this paper
• Towards a Rational and Efficient Diagnostic Approach in Children Referred for Growth Failure to the General Paediatrician

  2019cites this paper
• Assessment of somatotropic function in children with syndrome of biologically inactive growth hormone against a background of clonidine and insulin stimulation tests

  2019cites this paper
• Acquired neuro-secretory defect in growth hormone secretion due to Imatinib mesylate and the efficacy of growth hormone therapy in children with chronic myeloid leukemia

  2019cites this paper
• A Proposal for the Interpretation of Serum IGF-I Concentration as Part of Laboratory Screening in Children with Growth Failure

  2019cites this paper
• Idiopathic short stature and growth hormone sensitivity in prepubertal children

  2019cites this paper
• Dynamic Investigations and Diagnostic Testing

  2019cites this paper
• The role of insulin-like growth factor-1 generation test in diagnosis and prognosis of treatment for children with a preserved somatotropic function

  2019cites this paper
• Serum IGF-1 and short stature in adolescents with ß-thalassemia major

  2018cites this paper
• The growth hormone–insulin-like growth factor-I axis in the diagnosis and treatment of growth disorders

  2018cites this paper
• Nonclassical GH Insensitivity: Characterization of Mild Abnormalities of GH Action.

  2018cites this paper
• Short Stature in a Boy with Multiple Early-Onset Autoimmune Conditions due to a STAT3 Activating Mutation: Could Intracellular Growth Hormone Signalling Be Compromised?


  2017cites this paper
• LITHUANIAN UNIVERSITY OF HEALTH SCIENCES MEDICAL ACADEMY DEPARTMENT OF PEDIATRIC ENDOCRINOLOGY BY REFAAT YEHYA FACULTY OF MEDICINE COURSE VI GROUP 31 PREVALENCE AND CLINICAL MANIFESTATIONS OF SEVERE PRIMARY IGF-1 DEFICIENCY IN LITHUANIA

  2016cites this paper
• Diagnosis and management of growth disorders in Gulf Cooperation Council (GCC) countries: Current procedures and key recommendations for best practice

  2016cites this paper
• An unusual cause of short stature-Laron syndrome

  2016cites this paper
• Role of IGF-1 signaling in the pathology of diabetic retinopathy

  2015cites this paper
• Relation entre la méthylation des promoteurs du gène IGF1 et les variations de la croissance des enfants

  2015cites this paper
• Growth hormone insensitivity: diagnostic and therapeutic approaches

  2015cites this paper
• Genetic and Epigenetic Modulation of Growth Hormone Sensitivity Studied With the IGF-1 Generation Test

  2015cites this paper
• Clinical features and endocrine profile of Laron syndrome in Indian children

  2014cites this paper
• Characterization and prevalence of severe primary IGF1 deficiency in a large cohort of French children with short stature.

  2014cites this paper
• Clinical Features of a New Acid-Labile Subunit (IGFALS) Heterozygous Mutation: Anthropometric and Biochemical Characterization and Response to Growth Hormone Administration

  2013cites this paper
• Disorders of Growth Hormone in Childhood

  2013cites this paper
• Personalized Approach to Growth Hormone Treatment: Clinical Use of Growth Prediction Models

  2013cites this paper
• The utility of the IGF-I generation test in children with chronic kidney disease

  2013cites this paper
• Identification and management of poor response to growth‐promoting therapy in children with short stature

  2012cites this paper